Cancer News
AI-informed context on recent cancer research and oncology news

Wren Laboratories' NETest 2.0 Approved for Clinical Use: A Breakthrough for Neuroendocrine Tumors
June 6, 2026
Based on reporting from Newswise: MedNews
The New York State Department of Health has granted approval for Wren Laboratories' NETest 2.0, a next-generation blood test designed to detect and monitor neuroendocrine tumors (NETs). This...
Read more →
New Insights into NBCn1 Protein Could Pave the Way for Targeted Breast Cancer Therapies
June 6, 2026
Based on reporting from Newswise: MedNews
Recent research from UCLA has shed light on the role of a crucial protein, NBCn1, in helping breast cancer cells thrive in challenging environments. By understanding how this protein operates,...
Read more →
Advancements in Liver Cancer Treatment and AI Innovations at Cedars-Sinai
June 6, 2026
Based on reporting from Newswise: MedNews
Recent findings from Cedars-Sinai Cancer reveal significant progress in the fight against liver cancer, coupled with exciting developments in artificial intelligence (AI) that promise to enhance...
Read more →
New Combination Therapy Offers Hope for Patients with Aggressive Brain Cancer
June 6, 2026
Based on reporting from Newswise: MedNews
Recent findings from the STELLAR clinical trial have emerged as a beacon of hope for individuals battling grade 3 astrocytoma, an aggressive form of brain cancer. Conducted by the Huntsman Cancer...
Read more →
Transformative Philanthropy Fuels Cancer Clinical Trials at Rush University
June 6, 2026
Based on reporting from Newswise: MedNews
In a significant boost for cancer research and treatment, Rush University System for Health has received its largest philanthropic donation to date. The Harold B. Smith Foundation’s generous...
Read more →
New Cervical Cancer Screening Guidelines: A Game Changer for Early Detection
June 6, 2026
Based on reporting from Newswise: MedNews
The American Cancer Society (ACS) recently announced significant updates to its cervical cancer screening guidelines, an advancement that could reshape the landscape of early detection and treatment...
Read more →
Dr. Renuka Iyer Appointed Chief Medical Officer of NCCN: A New Era for Cancer Care Guidelines
June 6, 2026
Based on reporting from Newswise: MedNews
The National Comprehensive Cancer Network (NCCN), a leading alliance of top cancer centers, has appointed Dr. Renuka Iyer as its new Chief Medical Officer (CMO). This pivotal leadership change is...
Read more →
Dr. Renuka Iyer Takes the Helm as Chief Medical Officer of the NCCN: A New Era in Cancer Care Guidelines
June 6, 2026
Based on reporting from Newswise: Latest News
The National Comprehensive Cancer Network (NCCN) has announced the appointment of Dr. Renuka Iyer as its new Chief Medical Officer (CMO). This significant leadership change comes at a pivotal time...
Read more →
New Insights into Prostate Cancer Resistance Could Pave the Way for Innovative Treatments
June 6, 2026
Based on reporting from Newswise: MedNews
Recent research from the Desai Sethi Urology Institute and the Sylvester Comprehensive Cancer Center has unveiled a significant discovery that may transform the landscape of prostate cancer...
Read more →
New Insights into Prostate Cancer Resistance Could Pave the Way for Innovative Treatments
June 6, 2026
Based on reporting from Newswise: SciNews
Recent research from the Desai Sethi Urology Institute and Sylvester Comprehensive Cancer Center has unveiled critical new insights into the mechanisms behind prostate cancer, a condition that...
Read more →
New Insights into Prostate Cancer Resistance Could Pave the Way for Innovative Treatments
June 6, 2026
Based on reporting from Newswise: Latest News
Recent findings from researchers at the Desai Sethi Urology Institute and Sylvester Comprehensive Cancer Center have revealed significant new information about the mechanisms underlying prostate...
Read more →
New Insights into KRAS-Mutant Cancers: Targeting RASH3D19 to Overcome Treatment Resistance
June 6, 2026
Based on reporting from Newswise: SciNews
Recent research from The University of Texas MD Anderson Cancer Center has revealed a promising new target in the fight against KRAS-mutant cancers, which are notoriously difficult to treat. The...
Read more →
Exploring Innovative Sonodynamic Therapy for Advanced Abdominal Cancers
June 6, 2026
Based on reporting from Newswise: Latest News
Recent advancements in cancer treatment have led to the exploration of novel therapies that combine established techniques with innovative technologies. A first-in-human clinical trial has...
Read more →
Targeting Senescent Cells: A New Frontier in Lung Cancer Treatment
June 6, 2026
Based on reporting from Newswise: MedNews
Recent research from the University of California, San Francisco (UCSF) has uncovered a promising approach to combat lung cancer by targeting a unique population of aging cells known as senescent...
Read more →
Groundbreaking Blood Cancer Research Unveiled at ASH 2025 Annual Meeting
June 6, 2026
Based on reporting from Newswise: MedNews
The 67th American Society of Hematology (ASH) Annual Meeting, taking place from December 6-9, 2025, in Orlando, Florida, is set to showcase significant advancements in blood cancer research....
Read more →
New Advances in Blood Cancer Research Highlighted at ASH 2025
June 6, 2026
Based on reporting from Newswise: MedNews
The 67th American Society of Hematology (ASH) Annual Meeting and Exposition is set to showcase groundbreaking research from the Rutgers Cancer Institute and RWJBarnabas Health, focusing on blood...
Read more →
New Dean Dr. Eric Rohren Aims to Transform Cancer Care in El Paso
June 6, 2026
Based on reporting from Newswise: MedNews
In a significant move for cancer care in the Southwest, Dr. Eric M. Rohren has been appointed as the new dean of the Foster School of Medicine at Texas Tech University Health Sciences Center El Paso....
Read more →
Innovative Blood Test Aims to Enhance Lung Cancer Screening Adherence
June 6, 2026
Based on reporting from Newswise: MedNews
The battle against lung cancer is entering a new phase, thanks to a groundbreaking partnership between Hackensack Meridian Health and DELFI Diagnostics. Supported by a grant from Lilly, this...
Read more →
New Cell Death Pathway Discovered: Implications for Cancer Treatment
June 6, 2026
Based on reporting from Newswise: MedNews
Recent research from St. Jude Children's Research Hospital has unveiled a novel pathway for cell death, termed mitoxyperilysis, which could lead to innovative strategies in cancer treatment. The...
Read more →
New Pathway of Cell Death: Mitoxyperilysis and Its Implications for Cancer Treatment
June 6, 2026
Based on reporting from Newswise: Latest News
Recent research from St. Jude Children's Research Hospital has unveiled a novel pathway of cell death, named mitoxyperilysis, that may hold significant promise for cancer treatment. This discovery...
Read more →